FDA Fires Vinay Prasad, Biotech Left Swiping Left
In this week's episode of 'The Readout LOUD,' STAT's sharp biotech reporters dissect the drama behind Vinay Prasad's ouster from the FDA, leaving the biotech world wondering if this is a plot twist or just another episode of regulatory Game of Thrones. As the show bluntly puts it, they 'parse what Vinay Prasad's ouster means for biotech and the FDA,' because nothing says biotech thrill like politics and power moves thicker than a monoclonal antibody cocktail.
Share the Story
Vinay Prasad gets the boot and the biotech world collectively checks if FDA drama is now their new soap opera. Spoiler: No oneâs safe, and placebo effects are looking more like real ones.
Prasadâs exit proves biotech canât have nice things, especially when FDA offices feel more like reality TV voting circles. Whoâs nextâFrank Underwood with a lab coat?
FDA just threw Vinay Prasad out like last seasonâs leftover pipettes. Meanwhile, scientist emojis everywhere are loading their CRISPR guns for clout.
Source: Statnews | Published: 7/31/2025 | Author: Elaine Chen, Adam Feuerstein, and Matthew Herper
More Articles in Science
Politico Announces Australia Launch for 2026, Because Why Not Start Late?
Trump Promises Retirement Plan That Matches Generosity of Federal Workersâ Excuses
Trump Calls Supreme Court 'Unfortunate,' Then Hits Economy with âBetterâ 10% Global Tariff
Top Scientists Warn AI Might Soon Brew Bioweapons, But Letâs Keep Data Open Anyway
Elon Musk Delays Mars, Now Playing Fast and Loose with Moon Real Estate
Scientists Outsource Brainwork to AI, Still Take All the Credit
SpaceXâs Starlink Satellite Has Midlife Crisis, Explodes Dramatically
Scientists Officially Declare Adulthood Brain Is Just Long Teenage Brain Saga
